Impact News +++ Hugo Boss nimmt für Umbau 2026 Gewinn- und Umsatzrückgang in Kauf (Reuters) +++ HUGO BOSS Aktie -3,14%

ORION CORP Aktie

>ORION CORP Aktienkurs

64 EUR +4.2% (Tradegate)

Ask: 62.15 EUR / 700 Stück

Bid: 62 EUR / 700 Stück

Tagesumsatz: 80 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ORION CORP Aktie über LYNX handeln

Intraday

1 Jahr

>ORION CORP Performance

1 Woche: +1,3%

1 Monat: +0,5%

3 Monate: -8,7%

6 Monate: +1,4%

1 Jahr: +35,5%

laufendes Jahr: +42,5%

>ORION CORP Aktie

Name:

ORION CORP. B

Land:

Finnland

Sektor:

Gesundheit

ISIN/ Wkn:

FI0009014377 / A0J3QM

Symbol/ Ticker:

OFK (Frankfurt)

Kürzel:

FRA:OFK, ETR:OFK, OFK:GR

Index:

Webseite:

https://www.orion.fi/

Profil:

Orion Oyj is a leading Finnish pharmaceutical comp..
>Volltext..

Marktkapitalisierung:

8668.09 Mio. EUR

Unternehmenswert:

8755.27 Mio. EUR

Umsatz:

1646.36 Mio. EUR

EBITDA:

490.54 Mio. EUR

Nettogewinn:

316.52 Mio. EUR

Gewinn je Aktie:

2.25 EUR

Schulden:

314.7 Mio. EUR

Liquide Mittel:

226.57 Mio. EUR

Operativer Cashflow:

326.72 Mio. EUR

Bargeldquote:

0.41

Umsatzwachstum:

13.99%

Gewinnwachstum:

-5.58%

Dividende je Aktie:

1.64 EUR

Dividendenrendite:

2.66%

Dividendenschätzung:

2.68%

Div. Historie:

15.10.25 - 0.82€
04.04.25 - 0.82€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

ORION CORP, ORION OYJ, ORION CORPORATION

Letzte Datenerhebung:

03.12.25

>ORION CORP Kennzahlen

Aktien/ Unternehmen:

Aktien: 108.92 Mio. St.

Frei handelbar: 97.19%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: 3712

Umsatz/Mitarb.: 0.37 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 13.2%

Bewertung:

KGV: 27.59

KGV lG: 17.06

KUV: 5.2

KBV: 8.48

PEG-Ratio: -

EV/EBITDA: 17.85

Rentabilität:

Bruttomarge: 59.67%

Gewinnmarge: 19.23%

Operative Marge: 23.89%

Managementeffizenz:

Gesamtkaprendite: 18.67%

Eigenkaprendite: 32.23%

>ORION CORP Peer Group

Es sind 11 Aktien bekannt.

>ORION CORP Chart & Kurs - Tradegate

>ORION CORP News

03.12.25 - 08:03	Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025 (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 3 DECEMBER 2025 at 09.00 EET ...

27.11.25 - 08:03	71,498 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 NOVEMBER 2025 at 9.00 EET ...

14.11.25 - 12:33	Orion receives award for international growth from the President of the Republic of Finland (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 14 NOVEMBER 2025 at 13.30 EET Orion receives award for international growth from the President of the Republic of Finland...

28.10.25 - 12:12	Orion Oyj Q3 Profit Falls (AFX)
	HELSINKI (dpa-AFX) - Orion Oyj (0M2N.L) announced earnings for third quarter that Dropped, from last yearThe company's bottom line totaled EUR96 million, or EUR0.68 per share. This compares with E......

28.10.25 - 11:03	Orion Group Interim Report January–September 2025 (GlobeNewswire EN)
	ORION CORPORATION INTERIM REPORT 1–9/2025 28 OCTOBER 2025 at 12:00 EET...

24.10.25 - 08:03	49,164 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 OCTOBER 2025 at 9.00 EEST ...

23.10.25 - 14:33	Orion and Abzena announce exclusive commercial license for Abzena′s antibody (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 23 OCTOBER 2025 at 15:30 EEST Orion and Abzena announce exclusive commercial license for Abzena's antibody...

15.10.25 - 00:01	XFRA: DIVIDEND/INTEREST INFORMATION - 15.10.2025 - FI0009014377 (XETRA)
	Das Instrument OFK FI0009014377 ORION CORP. B EQUITY wird ex Dividende/Zinsen gehandelt am 15.10.2025 The instrument OFK FI0009014377 ORION CORP. B EQUITY has its ex-dividend/interest day on 15.10.2025...

14.10.25 - 10:18	Orion publishes Interim Report for January–September 2025 and holds a webcast on 28 October 2025 (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 14 OCTOBER 2025 at 11.15 EEST ...

30.09.25 - 12:03	Orion′s phase 2 study of ODM-105 in insomnia did not meet primary goal (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST ...

30.09.25 - 08:03	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 September 2025 at 9.00 EEST ...

26.09.25 - 15:33	Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025 at 16.30 EEST ...

19.09.25 - 08:03	80,802 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 19 SEPTEMBER 2025 at 9.00 EEST ...

20.08.25 - 08:03	337,000 Orion Corporation A shares converted into B shares (GlobeNewswire EN)
	ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 20 AUGUST 2025 at 9.00 EEST ...

13.08.25 - 10:12	Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries (PR Newswire)
	OSLO, Norway, Aug. 13, 2025 /PRNewswire/ -- Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation ("Orion"), the product......

13.08.25 - 09:54

Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries. (Cision)

Oslo, Norway – 2025.08.13 – Navamedic is pleased to announce that it has received final approval for the packaging material in national languages for Norway, Sweden and Denmark, following the earlier announcement on June 27th. Orion Corporation (“Orion”), the product licensor for Finland and the rest of the EU, has also obtained final confirmation for the Finnish market. "We are excited to have received the last approvals, paving the way for our go-to-market launch in the Nordic region," said Kathrine Gamborg Andreassen, Chief Executive Officer of Navamedic. Flexilev® in OraFID® ensures...

08.08.25 - 08:33	Orion Corporation: Managers′ transactions – Juhani Kankaanpää (GlobeNewswire EN)
	ORION CORPORATION MANAGERS' TRANSACTIONS 8 AUGUST 2025 at 9.30 EEST ...

04.08.25 - 15:12	Orion Corporation: Managers′ transactions – Satu Ahomäki (GlobeNewswire EN)
	ORION CORPORATION MANAGERS' TRANSACTIONS 4 August 2025 at 16:10 EEST ...

28.07.25 - 20:30	Here is Why Growth Investors Should Buy Orion OYJ (ORINY) Now (Zacks)
	Orion OYJ (ORINY) could produce exceptional returns because of its solid growth attributes....

21.07.25 - 09:33	Darolutamide receives EU approval in third indication for patients with advanced prostate cancer (GlobeNewswire EN)
	ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST ...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die deutschen politischen Schriftsteller, nicht an Geist fehlt es ihnen, aber an Mut. - Ludwig Börne

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram